Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Characterization of T-cell responses after oral KLH exposure in healthy volunteers
2011-001232-27Phase 2Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Dec 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of keyhole limpet hemocyanin, sponsored by Charité – Universitätsmedizin Berlin. Primary endpoint: Frequency of adverse events after oral and/or parenteral KLH administration. Started Dec 2011; status: completed.
02
Drugs
keyhole limpet hemocyanin
Beyond the preview
Go deeper on 2011-001232-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001232-27.